Citius Pharmaceuticals (CTXR) Market Capitalization (2014 - 2026)

Citius Pharmaceuticals (CTXR) has reported Market Capitalization for 13 consecutive years, with $16.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 5.88% year-over-year to $16.5 million; the trailing twelve-month figure through Jun 2026 stood at $16.5 million (down 5.88% YoY), and the FY2025 full-year result was $13.7 million, down 84.88% from the prior year.
• Market Capitalization slipped to $16.5 million in Q2 2026 per CTXR's latest filing, from $20.1 million in the prior quarter.
• Across five years, Market Capitalization topped out at $6.5 billion in Q1 2022 and bottomed at $13.1 million in Q1 2025.
• Historically, Market Capitalization has averaged $2.1 billion across 5 years, with a median of $2.7 billion in 2023.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization plunged 99.63% in 2025, then jumped 54.28% in 2026.
• Over 5 years, Market Capitalization stood at $2.9 billion in 2022, then increased by 4.15% to $3.0 billion in 2023, then sank by 98.97% to $30.9 million in 2024, then sank by 43.53% to $17.5 million in 2025, then dropped by 5.63% to $16.5 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $16.5 million, $20.1 million, and $17.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.